# A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)

> **NCT01502371** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 583 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg
- **DRUG:** Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg
- **DRUG:** Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg
- **DRUG:** Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg
- **DRUG:** Placebo Metered Dose Inhaler (MDI)
- **DRUG:** Placebo Dry Powder Inhaler (DPI)

## Key facts

- **NCT ID:** NCT01502371
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-25
- **Primary completion:** 2015-01-29
- **Final completion:** 2015-01-29
- **Target enrollment:** 583 (ACTUAL)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502371, "A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01502371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*